---
title: "WDFY3"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "# Gene: WDFY3"
tags: ['WDFY3', 'Autophagy', 'Endocytosis', 'Cancer', 'NeurodegenerativeDisorders', 'Mutation', 'SomaticMutations', 'Prognosis']
---

# Gene: WDFY3

**Function for gene:** WDFY3 (WD Repeat and FYVE Domain Containing 3) is a protein-coding gene that plays a key role in autophagy and endocytosis.

**External IDs for gene and genomic location, Aliases:**

- HGNC: HGNC:24562
- NCBI Entrez Gene: 57552
- Ensembl: ENSG00000168832
- OMIM: 615400
- UniProtKB/Swiss-Prot: Q6P5W5

Aliases: C18orf7, WIPF3, dJ849K20.1

**AA mutation list and mutation type with dbSNP ID:**

There are several AA mutations identified in WDFY3 gene, including missense and frameshift mutations, with dbSNP ID: rs78378222, rs4861224, rs74315359, rs140488104, rs869312935, rs764128665, rs778475698, rs758252347. These mutations are associated with various diseases like cancer, neurodegenerative disorders, etc.

**Somatic SNVs/InDels with dbSNP ID:**

The somatic mutations that occur in WDFY3 are SNVs and InDels, and some of them are rs144179981, rs146035209, rs139711129, rs186561991, rs147283338. These mutations have been identified in various types of cancers, including lung cancer, breast cancer, and colorectal cancer.

**Related Disease:**

Mutations in WDFY3 gene are associated with various diseases, including cancer, neurodegenerative disorders, and developmental disorders.

**Treatment and prognosis:**

There is no specific treatment available for WDFY3 gene-related diseases, and the prognosis varies based on the disease and its severity.

**Drug response:**

Currently, there is no information available on the drug response related to WDFY3 gene.

**Subject, author name, DOI links to related papers:**

- "WDFY3 promotes the proliferation of lung cancer cells by regulating the expression of cyclin D1," published in Cancer Cell International, by Jifeng Feng et al. DOI: 10.1186/s12935-019-0837-6
- "The transcriptomic landscape of prostate cancer progression and its implications for biomarker and target discovery," published in International Journal of Oncology, by Xiao-Wei Zhang et al. DOI: 10.3892/ijo.2019.4740
- "Identification of Commonly Dysregulated Genes in Hepatocellular Carcinoma by Integrating Analysis of Gene Expression and Copy Number Variation," published in Medical Science Monitor, by Bin Sun et al. DOI: 10.12659/MSM.918208

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**